Yahoo · Nov 14, 2026
CVS Health (CVS) Could Be 28% Undervalued As Its Recovery Narrative Builds
CVS Health (CVS) has jumped back into the spotlight after announcing the latest Caliber Artist Series journals, a small product move that still raises fresh questions about its retail brand power. Recent trading reflects that mix of headlines and hard numbers. CVS Health shares trade at US$89.35, with a 7 day share price return of 6.56% after a softer 90 day share price return of 8.04% and a 1 year total shareholder return of 18.36% that indicates momentum relative to a longer base. Scan how...


